NCT00002094View on ClinicalTrials.gov

Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Atevirdine mesylate

Trial Locations (1)

208995000

Natl Naval Med Ctr, Bethesda

All Listed Sponsors

lead

Pharmacia and Upjohn

INDUSTRY

NCT00002094 - Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E | Biotech Hunter | Biotech Hunter